United States · Telehealth platform · Compounded
24hrDoc review
Microdosing at $129 a month with ongoing dose adjustments — and no statement anywhere about whether the medication is compounded.
Overview
24hrDoc sells a “doctor-guided, low-dose GLP-1 protocol” at $110 for the first month, including the initial assessment, then $129/month ongoing. It advertises “no hidden fees” and “no commitment required” for the five-minute assessment, and “no insurance, no problem.”
The clinical description is better than several larger competitors: “licensed provider review of your health profile” and “ongoing monitoring & dose adjustments based on response.” Dose adjustment in a microdose programme is a meaningful commitment, since the whole model depends on staying below standard dosing.
The gap is the one that matters most for this tier. The page never states whether the medication is compounded. Every other microdose offering we verified — Noom, AgelessRx, Lemonaid — says so explicitly, because the approved products are not sold at those strengths. A microdose product that does not name its supply is asking you to take that on trust.
Medications and supply
Not stated. The page does not say whether the medication is compounded or brand-name, which is unusual for a microdose offering — the approved products are not marketed at microdose strengths.
- Low-dose GLP-1 (specific molecule and supply not stated)
How the service works
- Consultation
- A five-minute online assessment, described as carrying no commitment, followed by licensed provider review.
- Eligibility
- Determined by licensed provider review of your health profile.
- Provider involvement
- “Ongoing monitoring & dose adjustments based on response,” alongside the initial provider review.
- Lab requirements
- Not stated in the sources we checked.
- Pharmacy fulfilment
- Not stated in the sources we checked.
- Shipping
- Shipped following approval; timeline not specified.
- Support services
- Ongoing monitoring and dose adjustment, included in the monthly price.
What it costs
| Item | Published price | Notes |
|---|---|---|
| First month | $110 | includes the initial assessment |
| Ongoing | $129 / month | 15% off first order advertised |
- Membership fee
- Not stated separately — the monthly price appears to be all-in.
- Medication fee
- Not separated from the monthly price.
- Insurance
- Cash-pay — “no insurance, no problem.” Coverage is not otherwise addressed.
- HSA / FSA
- Not stated in the sources we checked.
- Cancellation
- The five-minute assessment is described as no-commitment, but full cancellation terms are not stated.
- Refunds
- Not stated in the sources we checked.
Pros
- Cheaper ongoing price than Noom for a comparable microdose product
- Ongoing monitoring and dose adjustment explicitly included
- No separate membership charge on top of the monthly price
- Free, no-commitment initial assessment
Cons
- Does not state whether the medication is compounded — the one disclosure a microdose product most needs
- Does not name the molecule
- Nothing published on labs, refunds, or shipping timing
- Cancellation terms undisclosed beyond the initial assessment
Who it may suit
Someone comparing microdose subscriptions on price who will ask what the medication actually is before their first shipment.
Limitations
- Supply and molecule both undisclosed, which makes the risk profile impossible to assess from the page
- Microdosing is not the dosing any published trial result was produced at
Questions
What does 24hrDoc cost?
$110 for the first month including the initial assessment, then $129/month ongoing, with no separate membership charge stated.
Is the medication compounded?
The page does not say. Every other microdose service we verified states it explicitly, because approved products are not sold at microdose strengths. Ask before ordering.
Sources
Everything on this page traces to one of the links below, retrieved on the date shown. Prices and programme terms in this market change without notice — confirm against the provider before you buy.
- 0124hrDoc — microdosing (pricing, clinician involvement, insurance stance)retrieved 2026-08-15